Literature DB >> 3160380

Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma.

A Balsari, G Fossati, D Taramelli, G Tona, D Delia, R Giardini, G Parmiani.   

Abstract

Killing of autologous melanoma (auto-Me) was obtained with pooled allostimulated peripheral blood lymphocytes (PBL) in 34/42 cases and found not to be due to a cross-reactivity between melanoma and allogeneic normal antigens. To see whether generation of tumour cytotoxic PBL by allostimulation was due to release of IL-2, PBL from 34 patients were divided into two aliquots and stimulated either by alloantigens or IL-2. Allostimulated PBL were cytotoxic for auto-Me in 30/34 cases (85%) whereas IL-2 generated tumour cytotoxic cells in 22/34 cases (64%). Lysis of K562, a target for monitoring NK-like activity, was obtained in 95-100% of cases with both stimuli. A similar frequency of OKT3+, OKT4+, OKT8+ and HNK1+ cells was found in PBL activated by allostimulation and IL-2, whereas a higher frequency of OKM1+ cells was evident in IL-2-stimulated PBL. Cold-target competition studies indicated that allostimulation generated at least two different types of effectors, one lytic to auto-Me but not to K562, and the other which lysed both targets. Allostimulated, FACS-separated T3- cells killed both auto-Me and K562 cells whereas T3+ cells lysed only auto-Me. It is concluded that allostimulation generated two subpopulations of auto-Me killer cells, one of the T lineage and the other NK-like, which both can destroy auto-Me targets.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160380      PMCID: PMC1977169          DOI: 10.1038/bjc.1985.151

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Authors:  J M Zarling; H I Robins; P C Raich; F H Bach; M L Bach
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

2.  Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.

Authors:  M López-Botet; A Silva; J Rodríguez; M O de Landazuri
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

3.  Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells.

Authors:  B M Vose; G D Bonnard
Journal:  Nature       Date:  1982-03-25       Impact factor: 49.962

4.  Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.

Authors:  P A Paciucci; S Macphail; J M Zarling; F H Bach
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

5.  Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.

Authors:  J M Zarling; F H Bach
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

6.  Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.

Authors:  J L Strausser; A Mazumder; E A Grimm; M T Lotze; S A Rosenberg
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.

Authors:  M T Lotze; E A Grimm; A Mazumder; J L Strausser; S A Rosenberg
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

8.  Definition of alien H-2 determinants on a Friend leukaemia by analysis of alloreactivity of CTL from primary MLC.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  J Immunogenet       Date:  1981-12

9.  Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

Authors:  F Vánky; T Gorsky; Y Gorsky; M G Masucci; E Klein
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  5 in total

1.  Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2.

Authors:  T Fukiage; H Murakami; M Eura; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivity.

Authors:  F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.

Authors:  R Somasundaram; S G Rao; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study.

Authors:  A Balsari; R Marolda; C Gambacorti-Passerini; G Sciorelli; G Tona; E Cosulich; D Taramelli; G Fossati; G Parmiani; N Cascinelli
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Proliferative and cytotoxic responses of human peripheral blood lymphocytes to autologous malignant effusions. An analysis at the clonal level.

Authors:  T E Roberts; U Shipton; M Moore
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.